Self-Expanding Stents Market Key Drivers, Analysis, Trends, Overview And Forecast To 2033

Global self-expanding stents market size is expected to reach $4.17 Bn by 2028 at a rate of 5.9%, segmented as by product type, gastrointestinal self-expanding stents, carotid self-expanding stents, endovascular self-expandable stents

Jul 30, 2024 - 13:28

Self-Expanding Stents Market Key Drivers, Analysis, Trends, Overview And Forecast To 2033

The self-expanding stents global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Self-Expanding Stents Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size -

The self-expanding stents market size has grown strongly in recent years. It will grow from $3.14 billion in 2023 to $3.31 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increased awareness, growth in aging population, expansion of indications for stent usage beyond coronary arteries, growth in disposable income levels, and increased adoption of minimally invasive procedures.

The self-expanding stents market size is expected to see strong growth in the next few years. It will grow to $4.17 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing prevalence of cardiovascular diseases, expansion of healthcare infrastructure, expansion of telemedicine services for remote consultation, growing incidence of peripheral arterial disease, and increase in the prevalence of chronic diseases. Major trends in the forecast period include technological advancements, bioresorbable stents, drug-eluting stents, minimally invasive procedures, and integration of artificial intelligence.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/self-expanding-stents-global-market-report

Scope Of Self-Expanding Stents Market

The Business Research Company's reports encompass a wide range of information, including:

Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
Drivers: Examination of the key factors propelling market growth.
Trends: Identification of emerging trends and patterns shaping the market landscape.
Key Segments: Breakdown of the market into its primary segments and their respective performance.
Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
Macro Economic Factors: Assessment of broader economic elements impacting the market.

Self-Expanding Stents Market Overview

Market Drivers -

The growing prevalence of cardiovascular diseases is expected to propel the growth of the self-expanding stents market going forward. Cardiovascular illnesses are abnormalities of the heart and blood vessels. The growing cases of cardiovascular diseases is due to obesity, an aging population, and genetic predispositions. Self-expanding stents are useful in the therapy of cardiovascular disorders, as it provide effective and minimally invasive therapeutic alternatives for both urgent and long-term patient demands. For instance, in March 2022, according to the Office for National Statistics, a UK-based national statistical authority, the number of deaths due to heart attacks was 20,061 in 2021, increasing from 19,440 in 2020. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the self-expanding stents market.

Market Trends -

Major companies operating in the self-expanding stents market are focusing their efforts on introducing solutions, such as tracheal stent system, to reduce the need for open surgery and gain a competitive edge in the market. A tracheal stent system is a medical device used to support and maintain the patency of the trachea, often employed in cases of tracheal stenosis or collapse. For instance, in February 2022, Micro-Tech Endoscopy Inc., a US-based medical technology company, launched a tracheobronchial nitinol y-stent. It is a flexible, self-expanding stent composed of a nitinol alloy with a low-profile delivery mechanism, a silicone coating to prevent tumor ingrowth, and repositionable sutures for adjustment or removal. For individuals suffering from tracheobronchial strictures, this stent relieves symptoms by expanding the airway and enhancing airflow.

The self-expanding stents market covered in this report is segmented –

1) By Product Type: Gastrointestinal Self-Expanding Stents, Carotid Self-Expanding Stents, Endovascular Self-Expandable Stents, Other Product Types

2) By Applications: Fem-Pop Artery Stents, Iliac Artery Stents, Carotid Artery Stents, Biliary Stents, Other Applications

3) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End-Users

Get an inside scoop of the self-expanding stents market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15667&type=smp

Regional Insights -

North America was the largest region in the self-expanding stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-expanding stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies -

Major companies operating in the self-expanding stents market are Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Becton, Dickinson and Company (BD Interventional), Terumo Corporation, Phenox GmbH, Balton Sp. z o.o., Biotronik SE & Co. KG, Merit Medical Systems Inc., Aesculap AG, MicroVention Inc., Lifetech Scientific Corporation, Cordis Corporation, Rontis Corporation, Veryan Medical Ltd., Andramed GmbH, Medinol Ltd., iVascular SLU, HEXACATH SAS, Eucatech AG, Endospan Ltd., Endo-Flex GmbH, Endocor GmbH

Table of Contents